Stefan Schneeberger, Vijay S Gorantla, Gerald Brandacher, Adriana Zeevi, Anthony J Demetris, John G Lunz, Diana M Metes, Albert D Donnenberg, Jaimie T Shores, Andrea F Dimartini, Joseph E Kiss, Joseph E Imbriglia, Kodi Azari, Robert J Goitz, Ernest K Manders, Vu T Nguyen, Damon S Cooney, Galen S Wachtman, Jonathan D Keith, Derek R Fletcher, Camila Macedo, Raymond Planinsic, Joseph E Losee, Ron Shapiro, Thomas E Starzl, W P Andrew Lee
OBJECTIVE: To minimize maintenance immunosuppression in upper-extremity transplantation to favor the risk-benefit balance of this procedure. BACKGROUND: Despite favorable outcomes, broad clinical application of reconstructive transplantation is limited by the risks and side effects of multidrug immunosuppression. We present our experience with upper-extremity transplantation under a novel, donor bone marrow (BM) cell-based treatment protocol ("Pittsburgh protocol")...
February 2013: Annals of Surgery